ENDRA Life Sciences Inc.

$5.55-0.72%($-0.04)
TickerSpark Score
57/100
Mixed
70
Valuation
20
Profitability
50
Growth
64
Health
80
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NDRA research report →

52-Week Range29% of range
Low $2.92
Current $5.55
High $11.96

Companywww.endrainc.com

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion.

CEO
Alexander Y. Tokman
IPO
2017
Employees
21
HQ
Ann Arbor, MI, US

Price Chart

+79.03% · this period
$8.84$5.96$3.09May 20Nov 18May 20

Valuation

Market Cap
$4.18M
P/E
-0.91
P/S
0.00
P/B
3.73
EV/EBITDA
-0.66
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-513.22%
ROIC
-236.33%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-7,027,410 · 38.93%
EPS
$-8.93 · 12.88%
Op Income
$-5,763,101
FCF YoY
29.89%

Performance & Tape

52W High
$11.96
52W Low
$2.92
50D MA
$4.69
200D MA
$4.85
Beta
-0.11
Avg Volume
109.72K

Get TickerSpark's AI analysis on NDRA

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 2, 26Tokman Alexander Yother26,921
Mar 2, 26Jacroux Richardother13,461
Jan 21, 26DIGIANDOMENICO ANTHONYother60,324
Jan 21, 26Harsh Michaelother60,324
Jan 21, 26Jacroux Richardother20,000
Jan 21, 26Basenese Louother60,324
Jan 21, 26Tokman Alexander Yother75,000
Oct 10, 25DIGIANDOMENICO ANTHONYother141,644
Oct 10, 25DIGIANDOMENICO ANTHONYother70,822
Jun 11, 25Basenese Louother5,384

Our NDRA Coverage

We haven't published any research on NDRA yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate NDRA Report →

Similar Companies